Patient perspectives on repeated MRI and PET/CT examinations during neoadjuvant treatment of oesophageal cancer.

CONCLUSION: Repeated imaging with both MRI and PET/CT is generally well-tolerated for the assessment of response to treatment in oesophageal cancer patients. Shorter acquisition times and altered body positioning during scanning will likely improve patient experience. Advances in knowledge: This paper demonstrates that MRI and PET/CT are generally well-tolerated imaging procedures for the assessment of response to treatment in esophageal cancer patients. When asked to rank different tests, patients preferred MRI over PET/CT and endoscopy.
PMID: 29498535 [PubMed - as supplied by publisher]

Source: The British Journal of Radiology - March 2, 2018 Category: Radiology Authors: Goense L, Borggreve AS, Heethuis SE, van Lier AL, van Hillegersberg R, Mook S, Meijer GJ, van Rossum PS, Ruurda JP Tags: Br J Radiol Source Type: research